Skip to main content


EDM (Early Day Motion) 2418: tabled on 09 November 2011

Tabled in the 2010-12 session.

This motion has been signed by 26 Members. It has not yet had any amendments submitted.

As this motion is using historical data, we may not have the record of the original ordering, in which case signatories are listed alphabetically.

Motion text

That this House notes the importance of the aims of the Antibiotic Action Initiative of the British Society for Antimicrobial Chemotherapy that is examining ways to encourage the discovery, research and development to bring to market new antibacterial agents; further notes the need to ensure that licensing processes are streamlined to provide safe and rapid licensing of antibiotics; understands the need to stimulate industry to overcome the challenges in developing and bringing to market new antibiotics; and supports a drive for initiatives to encourage more partnership working between academia, pharmaceutical and diagnostics companies in order to maximise the conversion of discovered candidate molecules into licensed antibiotics available for use on the NHS.

The first 6 Members who have signed to support the motion are the sponsors. The primary sponsor is generally the person who tabled the motion and has responsibility for it. The date shown is when the Member signed the motion.

In addition to the sponsors, the following Members have signed to support the motion.

There are no withdrawn signatures for this motion.